Tango Therapeutics, Inc. (TNGX)
Tango Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in discovering and delivering precision cancer medicines. It also identifies novel targets and develops new drugs directed at tumor suppressor gene loss in defined patient populations with high unmet medical need. The company was founded by Alan Ashworth, William G. Kaelin, Jr., Jose Baselga, and Antoni Ribas in 2017 and is headquartered in Boston, MA.
Address
201 BROOKLINE AVENUE
BOSTON, MA 02215
Founded
2017
Number of Employees
140
Website
http://www.tangotx.com
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)